v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
REVENUES        
Total revenues $ 1,117,935 $ 904,067 $ 3,017,430 $ 2,360,823
EXPENSES        
Cost of product sales 916,624 807,922 2,119,103 1,799,574
General and administrative 2,952,100 1,979,614 5,826,038 2,897,993
Research and development 4,508,466 597,345 8,007,840 835,403
Sales and marketing 135,543 88,844 272,129 181,106
Total expenses 8,512,733 3,473,725 16,225,110 5,714,076
LOSS FROM OPERATIONS (7,394,798) (2,569,658) (13,207,680) (3,353,253)
OTHER (INCOME) EXPENSE, NET        
Loss (gain) on change in fair value of warrant liabilities (2,075,100) 16,201,400 (4,198,000) 16,201,400
Interest (income) expense, net (12,718) 57,364 (30,061) 148,121
Other (income), net (2,352) (250,114) (2,894) (251,272)
Total other (income) expense, net (2,090,170) 16,008,650 (4,230,955) 16,098,249
LOSS BEFORE PROVISION FOR INCOME TAXES (5,304,628) (18,578,308) (8,976,725) (19,451,502)
PROVISION (BENEFIT) FOR INCOME TAXES 605 597 1,135 (22)
NET LOSS $ (5,305,233) $ (18,578,905) $ (8,977,860) $ (19,451,480)
Net loss per common share, basic and diluted $ (0.18) $ (2.12) $ (0.31) $ (2.71)
Weighted—average number of shares outstanding, basic and diluted 28,850,451 8,746,250 28,510,014 7,174,233
Net Product Sales [Member]        
REVENUES        
Total revenues $ 1,117,935 $ 904,067 $ 2,538,776 $ 2,315,823
License Revenue [Member]        
REVENUES        
Total revenues 478,654
Collaborative Research Revenue [Member]        
REVENUES        
Total revenues $ 45,000

Source